Σύγκριση μεθόδων

	Ερωτηματολόγιο EORTC QLQ-BR23: Ποιότητα Ζωής στον Καρκίνο του Μαστού	EORTC QLQ-LC13: Ποιότητα Ζωής στον Καρκίνο του Πνεύμονα
Πεδίο	Ογκολογία	Ογκολογία
Οικογένεια	Process / pipeline	Process / pipeline
Έτος προέλευσης	1996	1994
Δημιουργός	Sprangers, M. A., et al. (EORTC Quality of Life Group)	Bergman, B., et al. (EORTC Quality of Life Group)
Τύπος	Self-report questionnaire	Self-report questionnaire
Θεμελιώδης πηγή	Sprangers, M. A., Groenvold, M., Arraras, J. I., Franklin, J., te Velde, A., Muller, M., et al. (1996). The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol, 14(10), 2756–2768.	Bergman, B., Aaronson, N. K., Ahmedzai, S., Kaasa, S., & Sullivan, M. (1994). The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials. Eur J Cancer, 30A(5), 635–642.
Εναλλακτικές ονομασίες	QLQ-BR23	QLQ-LC13
Συναφείς	5	5
Σύνοψη	The EORTC QLQ-BR23 is a 23-item breast-cancer-specific module designed to complement the 30-item EORTC QLQ-C30 core questionnaire, assessing functional and symptom domains unique to breast cancer. Validated by Sprangers et al. in 1996, it measures body image, sexual function, breast symptoms, and arm symptoms, making it a standard instrument in European and international breast cancer clinical trials and quality-of-life research.	The EORTC QLQ-LC13 is a 13-item lung-cancer-specific module designed to complement the 30-item EORTC QLQ-C30 core questionnaire. Developed and validated by Bergman et al. in 1994, it measures lung-specific symptoms (dyspnea, cough, hemoptysis, chest pain) and treatment toxicities (sore mouth, dysphagia). It is the standard lung cancer-specific QoL instrument in European and international trials.